Successful use of intravenous immunoglobulins in Landau-Kleffner syndrome

Pediatric Neurology

Volumn 18, Issue 2, 1998, Pages 165-168

  Lagae, Lieven G ^a   Silberstein, Jon ^a   Gillis, Phillippe L ^b   Casaer, Paul J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b VIRGA JESSE HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; CASE REPORT; CLINICAL FEATURE; ELECTROENCEPHALOGRAM; FOCAL EPILEPSY; HUMAN; IMMUNOTHERAPY; LANDAU KLEFFNER SYNDROME; LANGUAGE DEVELOPMENT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0032007088     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(97)00157-4     Document Type: Article

References (25)

1. [1] Landau WM, Kleffner FR. Syndrome of acquired aphasia with convulsive disorder in children. Neurology 1957;7:523-30.
2. [2] Otero E, Cordova S, Diaz F, Garcia-Teruel I, Del Brutto OH. Acquired epileptic aphasia (the Landau-Kleffner syndrome) due to neurocysticercosis. Epilepsia 1989;30:569-72.
3. [3] Michaoowicz R, Jozwiak S, Ignatowitz R, Szwabowska-Orzeszko E. Landau-Kleffner syndrome - epileptic aphasia in children -possible role of toxoplasma gondii infection. Acta Paediatr Hung 1989;29:337-42.
4. [4] Martinez-Bermejo A, Pascual Castraviejo I, Lopez-Martin V, Arcas J, Perez-Higueras A. Acquired aphasia syndrome with epilepsy (Landau-Kleffner syndrome) secondary to cerebral arteritis. Neurologia 1989;4:296-9.
5. [5] Pascual Castraviejo I, Lopez-Martin V, Martinez Bermejo A, Perez Higueras A. Is cerebral arteritis the cause of the Landau-Kleffner syndrome? Four cases in childhood with angiographic study. Can J Neurol Sci 1992;19:46-52.
6. [6] Solomon GE, Carson D, Pavlakis S, Fraser R, Labar D. Intracranial EEG monitoring in Landau-Kleffner syndrome associated with left temporal lobe astrocytoma. Epilepsia 1993;34:557-60.
7. [7] Perniola T, Margari L, Buttiglione M, Andreula C, Simone IL, Santastasi R. A case of Landau-Kleffner syndrome secondary to inflammatory demyelinating disease. Epilepsia 1993;34:551-6.
8. [8] Lerman P, Lerman-Sagie T, Kivity S. Effect of early corticosteroid therapy for Landau-Kleffner syndrome. Dev Med Child Neurol 1991:33:257-60.
9. [9] Morrell F, Whisler WW, Smith MC. et al. Landau-Kleffner syndrome: Treatment with subpial intracortical transection. Brain 1995; 118:1529-46.
10. [10] Sawhney IM, Robertson IJ, Polkey CE, Binnie CD, Elwes RD. Multiple subpial transection: A review of 21 cases. J Neurol Neurosurg Psychiatr 1995;58:344-9.
11. [11] Deonna T, Beaumanoir A, Gaillard F, Assal G. Acquired aphasia in childhood with seizure disorder: A heterogeneous syndrome. Neuropediatrie 1977;8:263-73.
12. [12] Deonna TW. Acquired epileptiform aphasia in children (Landau-Kleffner syndrome). J Clin Neurophysiol 1991;8:288-98.
13. [13] Zardini G, Molteni B, Nardocci N, Sarti D, Avanzini G, Granata T. Linguistic development in a patient with Landau Kleffner syndrome: A nine-year follow-up. Neuropediatrics 1995;26:19-25.
14. [14] Lanzi G, Veggiotti P, Conte S, Partesana E, Resi C. A correlated fluctuation of language and EEG abnormalities in a case of the Landau Kleffner syndrome. Brain Dev 1994;16:329-34.
15. [15] Boel M, Casaer P. Continuous spikes and waves during slow sleep: A 30-month follow-up study of neuropsychological recovery and EEG findings. Neuropediatrics 1989;20:176-80.
16. [16] Scheffer IE, Jones L, Pozzebon M, Howell RA, Saling MM, Berkovic SF. Autosomal dominant rolandic epilepsy and speech dyspraxia: A new syndrome with anticipation. Ann Neurol 1995;38: 633-42.
17. [17] Deonna TW, Roulét E, Fontan D, Marcoz JP. Speech and oromotor deficits of epileptic origin in benign partial epilepsy of childhood with rolandic spikes (BPERS): Relationship to the acquired aphasia-epilepsy syndrome. Neuropediatrics 1993;24:83-7.
18. [18] Thornton CA, Griggs RC. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann Neurol 1994: 35:260-8.
19. [19] Duse M, Notarangelo D, Tiberti S, Menegati E, Plebani A, Ugazio AG. Intravenous immune globulin in the treatment of intractable childhood epilepsy. Clin Exp Immunol 1996;104(Suppl 1):71-6.
20. [20] Ballow M, White W, Desbonnet C. Modulation of in vitro synthesis of immunoglobulins and the induction of suppressor activity by therapy with intravenous immune globulin. J Allergy Clin Immunol 1989;84:595-602.
21. [21] Rossi F, Kazatchkine MD. Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J Immunol 1989;143:4104-9.
22. [22] Frank MM, Basta M, Fries LF. The effects of intravenous immune globulin on complement-dependent immune damage of cells and tissues. Clin Immunol Immunopathol 1992;62(Suppl):S82-S6.
23. [23] Illum N, Taudorf K, Heilmann C, et al. Intravenous immunoglobulin: A single-blind trial in children with Lennox-Gastaut syndrome. Neuropediatrics 1990;21:87-90.
24. [24] Van Rijckevorsel-Harmant K, Delire M, Schmitz-Moorman W, Wieser HG. Treatment of refractory epilepsy with intravenous immunoglobulins. Results of the first double-blind/dose finding clinical study. Int J Clin Lab Res 1994;24:162-6.
25. [25] Landau WM. Landau-Kleffner syndrome: An eponymic badge of ignorance. Arch Neurol 1992;49:353.